Tirzepatide Efficacy and Tolerability According to Early Weight Response: A Post Hoc Analysis of the SURMOUNT-1 and SURMOUNT-2 Trials.
Saved in:
| Title: | Tirzepatide Efficacy and Tolerability According to Early Weight Response: A Post Hoc Analysis of the SURMOUNT-1 and SURMOUNT-2 Trials. |
|---|---|
| Authors: | Kokkinos A; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece., Thethi T; AdventHealth, Translational Research Institute and AdventHealth Diabetes, Obesity and Endocrinology Institute, Orlando, Florida, USA., Lee CJ; Eli Lilly and Company, Indianapolis, Indiana, USA., Neff LM; Eli Lilly and Company, Indianapolis, Indiana, USA., Stefanski A; Eli Lilly and Company, Indianapolis, Indiana, USA., Cao D; Eli Lilly and Company, Indianapolis, Indiana, USA., Rodriguez A; Eli Lilly and Company, Indianapolis, Indiana, USA., Bartee A; Eli Lilly and Company, Indianapolis, Indiana, USA. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jun 25. Date of Electronic Publication: 2026 Jun 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.71009 |
